MARKET

ADPT

ADPT

Adaptive Biotechnologies
NASDAQ
8.42
-0.02
-0.24%
After Hours: 8.42 0 0.00% 16:02 03/30 EDT
OPEN
8.53
PREV CLOSE
8.44
HIGH
8.67
LOW
8.21
VOLUME
520.87K
TURNOVER
0
52 WEEK HIGH
15.19
52 WEEK LOW
5.96
MARKET CAP
1.21B
P/E (TTM)
-5.9899
1D
5D
1M
3M
1Y
5Y
Philips (PHG) Drives Health Care Prospects With New Solutions
NASDAQ · 2d ago
Adaptive Biotechnologies Shares Cross Above 200 DMA
NASDAQ · 3d ago
Sanofi's (SNY) Dupixent Meets Goal in Pivotal COPD Study
NASDAQ · 03/23 17:39
BridgeBio Pharma (BBIO) Surges 77% YTD: Here's Why
NASDAQ · 03/22 17:13
Luminar Technologies, EHang Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga · 03/22 11:05
SPLK, HA and PRPL are among after hour movers
Seeking Alpha · 03/21 20:57
Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study
NASDAQ · 03/21 14:35
Esperion (ESPR) Plummets 54% Over Milestone Payment Row
NASDAQ · 03/17 16:57
More
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on using the biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine (IM) platform combines a suite of chemistry, computational biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its clinical diagnostic product, clonoSEQ, is used for the detection and monitoring minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL). The IM business consists of two areas: IM Pharma Services and Drug Discovery. Its immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA).

Webull offers kinds of Adaptive Biotechnologies Corp stock information, including NASDAQ:ADPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADPT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ADPT stock methods without spending real money on the virtual paper trading platform.